Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-15
R
Ryan K Dare
Researcher
Also affiliated: University of London (1972); Centers for Disease Control and Prevention (2007–2010); Southern Illinois University School of Medicine (2024); University of Arkansas Medical Center (2025); Central Arkansas Veterans Healthcare System (2023); Baptist Health Foundation (2025); University of Pittsburgh Medical Center (2007–2008); Association Clinique et Thérapeutique Infantile du Val de Marne (2023–2024); Vanderbilt University Medical Center (2016)
Faculty Researcher
16 h-index
66 pubs
1,770 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Ryan K Dare's research focuses on the clinical aspects of infectious diseases, with a particular emphasis on patient outcomes and treatment strategies. His work includes investigations into bacterial bloodstream infections, comparing diagnostic tools, and evaluating the impact of rapid testing on antimicrobial stewardship. Dare has also studied risk factors and clinical outcomes associated with blood culture contamination, contributing to improved diagnostic accuracy and patient care.
His research extends to severe respiratory infections, including COVID-19 pneumonia, where he has examined the effectiveness of various therapeutic agents and identified risk factors for disease progression and mortality. Dare's publications also address the emergence of antimicrobial resistance, such as cefiderocol resistance in *Acinetobacter baumannii*, and the comparison of fungal diagnostic tests for conditions like histoplasmosis. His scholarship metrics include an h-index of 16 with over 1,700 citations across 65 publications.
Metrics
- h-index: 16
- Publications: 66
- Citations: 1,770
Selected Publications
-
Real-time Nanopore de novo assembly of ESKAPE pathogens: Implications for antibiotic stewardship (2026)
-
Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae (2025)
-
Evaluation of Antibiotic Selection in the Emergency Department Following the Implementation of an Infectious Source-Specific Order Set (2025)
-
Measurement of Practice-Level Antibiotic Utilization in a Medicaid Patient-Centered Medical Home Program (2025)
-
Device Evaluation, Treatment, and Explantation Recommendations (DETER): Review and Best Practices for Managing Neuromodulation Device Infections (2025)
-
It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis (2025)
-
P-842. Community-onset vs. Hospital-onset <i>Staphylococcus aureus</i> Bacteremia: Implications for Patients and Healthcare Systems (2025)
-
Dalbavancin Use in Bone and Joint Infections (2024)
-
Diagnostic utility of nasal methicillin-resistant <i>Staphylococcus aureus</i> polymerase chain reaction testing in head and neck infection (2024)
-
Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i> (2024)
-
Fractal Changes of the Retinal Microvasculature in Syphilitic Uveitis (2024)
-
A Tale of Mummified Eggs in Urine of a US Veteran (2024)
-
159. Diagnostic Utility of Nasal Methicillin-resistant <i>Staphylococcus aureus</i> Polymerase Chain Reaction Testing in Head and Neck Infection (2023)
-
2902. Dalbavancin Use in Bone and Joint Infections (2023)
-
Development of VRE meningitis due to haematogenous spread while on high-dose daptomycin therapy (2023)
Grants & Funding
As listed on this researcher's institutional profile.
- Healthcare Facility Reporting of Antibiotic Use/Antibiotic Resistance Data Incentive Project Centers for Disease Control & Prevention via Arkansas Department of Health & Human Services
- Real-Time High Resolution Method for Genomic
- Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-1 IM) NIH
- 24360 (IRB 261851) CTSA (Subaward) - Randomized Master Protocol for Immune Modulators for Treating COVID-19 DHHS - Biomedical Advanced Research and Development Authority via Duke University
Collaboration Network
Top Collaborators
Juan Carlos Rico Crescencio
University of Arkansas for Medical Sciences
6 shared publications
In database
- 519. Risk Factor Analysis for Hospital Admission Following <i>Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2</i>) Monoclonal Antibody Treatment
- Treatment of COVID-19 Patients with Two Units of Convalescent Plasma in a Resource-Constrained State
- 1790. Dethroning Vancomycin: A Multifaceted Stewardship Approach to Reduce Vancomycin in an Academic Medical Center
- 1273. Implementation of a Mobile Phone Intervention Method to Improve Clinical Outcomes in Patients with HIV
- 1791. Leveraging EMR Alerts for Vancomycin Time Outs
Showing 5 of 6 shared publications
Katherine Lusardi
4 shared publications
- Development of VRE meningitis due to haematogenous spread while on high-dose daptomycin therapy
- 1790. Dethroning Vancomycin: A Multifaceted Stewardship Approach to Reduce Vancomycin in an Academic Medical Center
- 1791. Leveraging EMR Alerts for Vancomycin Time Outs
- Evaluation of Antibiotic Selection in the Emergency Department Following the Implementation of an Infectious Source-Specific Order Set
Brett Bailey
University of Arkansas for Medical Sciences
4 shared publications
In database
- Dalbavancin Use in Bone and Joint Infections
- 2902. Dalbavancin Use in Bone and Joint Infections
- 1790. Dethroning Vancomycin: A Multifaceted Stewardship Approach to Reduce Vancomycin in an Academic Medical Center
- 1791. Leveraging EMR Alerts for Vancomycin Time Outs
Jacob T. Painter
University of Arkansas Medical Center
3 shared publications
In database
- Risk factors and clinical outcomes associated with blood culture contamination
- 933. Antibiotic Prescribing Changes in Adults During COVID-19 in Outpatient Patient-Centered Medical Homes (PCMH) in Arkansas
- Measurement of Practice-Level Antibiotic Utilization in a Medicaid Patient-Centered Medical Home Program
Eric Rosenbaum
University of Arkansas for Medical Sciences
3 shared publications
In database
- Real-World Impact of the Accelerate PhenoTest BC Kit on Patients With Bloodstream Infections in the Improving Outcomes and Antimicrobial Stewardship Study: A Quasiexperimental Multicenter Study
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit
Srivani Sanikommu
University of Arkansas for Medical Sciences (US)
3 shared publications
- Dalbavancin Use in Bone and Joint Infections
- Development of VRE meningitis due to haematogenous spread while on high-dose daptomycin therapy
- 2902. Dalbavancin Use in Bone and Joint Infections
Jacob M. Keck
University of Arkansas for Medical Sciences
3 shared publications
In database
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis
- Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae
Priyenka Thapa
2 shared publications
- Risk factors for mortality and progression to severe COVID-19 disease in the Southeast region in the United States: A report from the SEUS Study Group
- A Tale of Mummified Eggs in Urine of a US Veteran
Shawn H. MacVane
Accelerated Medical Diagnostics (United States) (US)
2 shared publications
- Real-World Impact of the Accelerate PhenoTest BC Kit on Patients With Bloodstream Infections in the Improving Outcomes and Antimicrobial Stewardship Study: A Quasiexperimental Multicenter Study
- Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit
Amira A. Bhalodi
Accelerated Medical Diagnostics (United States) (US)
2 shared publications
- Real-World Impact of the Accelerate PhenoTest BC Kit on Patients With Bloodstream Infections in the Improving Outcomes and Antimicrobial Stewardship Study: A Quasiexperimental Multicenter Study
- Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit
Kaleb Wolfe
University of Arkansas for Medical Sciences (US)
2 shared publications
- Real-World Impact of the Accelerate PhenoTest BC Kit on Patients With Bloodstream Infections in the Improving Outcomes and Antimicrobial Stewardship Study: A Quasiexperimental Multicenter Study
- Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit
Bradley Ford
University of Iowa Hospitals and Clinics (US)
2 shared publications
- Real-World Impact of the Accelerate PhenoTest BC Kit on Patients With Bloodstream Infections in the Improving Outcomes and Antimicrobial Stewardship Study: A Quasiexperimental Multicenter Study
- Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit
Dilek İnce
University of Iowa Hospitals and Clinics (US)
2 shared publications
- Real-World Impact of the Accelerate PhenoTest BC Kit on Patients With Bloodstream Infections in the Improving Outcomes and Antimicrobial Stewardship Study: A Quasiexperimental Multicenter Study
- Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit
Patrick Kinn
University of Iowa Hospitals and Clinics (US)
2 shared publications
- Real-World Impact of the Accelerate PhenoTest BC Kit on Patients With Bloodstream Infections in the Improving Outcomes and Antimicrobial Stewardship Study: A Quasiexperimental Multicenter Study
- Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit
Kelly M Percival
University of Iowa Hospitals and Clinics (US)
2 shared publications
- Real-World Impact of the Accelerate PhenoTest BC Kit on Patients With Bloodstream Infections in the Improving Outcomes and Antimicrobial Stewardship Study: A Quasiexperimental Multicenter Study
- Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit
Similar Researchers
Based on overlapping research topics
Juan Carlos Rico
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Antimicrobial Resistance in Bacteria
Kaitlin Cockerell
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Health Disparities and Outcomes
J. RICHARD ALLISON
University of Arkansas for Medical Sciences
Microbial infections and disease research
Retrospective Studies
Medical Case Reports
Haley Long
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Retrospective Studies
Vignesh J. Krishnan
University of Arkansas for Medical Sciences
Microbial infections and disease research
Retrospective Studies
Medical Case Reports
Laura Gonzalez
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Medical Case Reports